Body composition matters in almost every sport. Power-to-weight ratio, endurance and injury risk are all linked to how much fat and muscle an athlete carries. That is why sport scientists are paying close attention to one of the biggest areas of metabolic research of the last decade: GLP-1 based peptides.
From semaglutide to triple agonists
GLP-1 (glucagon-like peptide-1) is a hormone the gut releases after eating. It slows stomach emptying, increases fullness and helps regulate blood sugar. Medicines based on it, such as semaglutide, showed weight loss of around 15% in large clinical trials.
Researchers then asked whether targeting more than one hormone receptor could do even more. Tirzepatide acts on two receptors, GLP-1 and GIP. Retatrutide goes further and acts on three: GLP-1, GIP and glucagon. In a 48-week Phase 2 trial published in the New England Journal of Medicine in 2023, participants on the highest retatrutide dose lost an average of around 24% of body weight, the largest result reported for this class at the time.
Why sport scientists are interested
Weight loss on its own is not the goal in sport. The bigger research questions are about what kind of weight is lost:
Lean mass: how much of the weight lost is muscle rather than fat, and whether training can protect muscle during rapid weight change.
Energy and performance: whether lower appetite affects an athlete’s ability to fuel training properly.
Glucagon’s role: retatrutide’s glucagon activity is thought to increase energy expenditure, which makes it especially interesting for metabolism research.
These questions are being explored in laboratory and clinical research settings. Retatrutide is not a licensed medicine in the UK, and none of these compounds have a place in competitive sport.
The research supply question
Because retatrutide is still investigational, laboratories studying it source it as a research compound. That makes quality the biggest concern. Labs should only use batches with independent third-party HPLC and mass spectrometry results.
For UK research teams, this retatrutide UK guide explains what to look for in a supplier, including verifiable batch certificates and correct storage.
Conclusion
GLP-1 research has moved from one hormone to three in just a few years, and retatrutide sits at the front of that change. For sport science, the most important questions are about body composition rather than the number on the scales, and those answers will come from careful, well-controlled research.
This article is for general information only. Research peptides are sold for laboratory research use only and are not for human consumption.